161 related articles for article (PubMed ID: 31595312)
1. A single-center study of the clinicopathologic correlates of gliomas with a MYB or MYBL1 alteration.
Chiang J; Harreld JH; Tinkle CL; Moreira DC; Li X; Acharya S; Qaddoumi I; Ellison DW
Acta Neuropathol; 2019 Dec; 138(6):1091-1092. PubMed ID: 31595312
[No Abstract] [Full Text] [Related]
2. Isomorphic diffuse glioma is a morphologically and molecularly distinct tumour entity with recurrent gene fusions of MYBL1 or MYB and a benign disease course.
Wefers AK; Stichel D; Schrimpf D; Coras R; Pages M; Tauziède-Espariat A; Varlet P; Schwarz D; Söylemezoglu F; Pohl U; Pimentel J; Meyer J; Hewer E; Japp A; Joshi A; Reuss DE; Reinhardt A; Sievers P; Casalini MB; Ebrahimi A; Huang K; Koelsche C; Low HL; Rebelo O; Marnoto D; Becker AJ; Staszewski O; Mittelbronn M; Hasselblatt M; Schittenhelm J; Cheesman E; de Oliveira RS; Queiroz RGP; Valera ET; Hans VH; Korshunov A; Olar A; Ligon KL; Pfister SM; Jaunmuktane Z; Brandner S; Tatevossian RG; Ellison DW; Jacques TS; Honavar M; Aronica E; Thom M; Sahm F; von Deimling A; Jones DTW; Blumcke I; Capper D
Acta Neuropathol; 2020 Jan; 139(1):193-209. PubMed ID: 31563982
[TBL] [Abstract][Full Text] [Related]
3. cIMPACT-NOW update 4: diffuse gliomas characterized by MYB, MYBL1, or FGFR1 alterations or BRAF
Ellison DW; Hawkins C; Jones DTW; Onar-Thomas A; Pfister SM; Reifenberger G; Louis DN
Acta Neuropathol; 2019 Apr; 137(4):683-687. PubMed ID: 30848347
[No Abstract] [Full Text] [Related]
4. MYB/MYBL1::QKI fusion-positive diffuse glioma.
Suh YY; Lee K; Shim YM; Phi JH; Park CK; Kim SK; Choi SH; Yun H; Park SH
J Neuropathol Exp Neurol; 2023 Feb; 82(3):250-260. PubMed ID: 36592415
[TBL] [Abstract][Full Text] [Related]
5. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology.
Qaddoumi I; Orisme W; Wen J; Santiago T; Gupta K; Dalton JD; Tang B; Haupfear K; Punchihewa C; Easton J; Mulder H; Boggs K; Shao Y; Rusch M; Becksfort J; Gupta P; Wang S; Lee RP; Brat D; Peter Collins V; Dahiya S; George D; Konomos W; Kurian KM; McFadden K; Serafini LN; Nickols H; Perry A; Shurtleff S; Gajjar A; Boop FA; Klimo PD; Mardis ER; Wilson RK; Baker SJ; Zhang J; Wu G; Downing JR; Tatevossian RG; Ellison DW
Acta Neuropathol; 2016 Jun; 131(6):833-45. PubMed ID: 26810070
[TBL] [Abstract][Full Text] [Related]
6. Characterizing temporal genomic heterogeneity in pediatric low-grade gliomas.
Lazow MA; Hoffman L; Schafer A; Osorio DS; Boué DR; Rush S; Wright E; Lane A; DeWire-Schottmiller MD; Smolarek T; Sipple J; Taggert H; Reuss J; Salloum R; Hummel TR; de Blank P; Pillay-Smiley N; Sutton ME; Asher A; Stevenson CB; Drissi R; Finlay JL; Fouladi M; Fuller C
Acta Neuropathol Commun; 2020 Nov; 8(1):182. PubMed ID: 33153497
[TBL] [Abstract][Full Text] [Related]
7. Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.
Ramkissoon LA; Horowitz PM; Craig JM; Ramkissoon SH; Rich BE; Schumacher SE; McKenna A; Lawrence MS; Bergthold G; Brastianos PK; Tabak B; Ducar MD; Van Hummelen P; MacConaill LE; Pouissant-Young T; Cho YJ; Taha H; Mahmoud M; Bowers DC; Margraf L; Tabori U; Hawkins C; Packer RJ; Hill DA; Pomeroy SL; Eberhart CG; Dunn IF; Goumnerova L; Getz G; Chan JA; Santagata S; Hahn WC; Stiles CD; Ligon AH; Kieran MW; Beroukhim R; Ligon KL
Proc Natl Acad Sci U S A; 2013 May; 110(20):8188-93. PubMed ID: 23633565
[TBL] [Abstract][Full Text] [Related]
8. New strategies in pediatric gliomas: molecular advances in pediatric low-grade gliomas as a model.
Raabe E; Kieran MW; Cohen KJ
Clin Cancer Res; 2013 Sep; 19(17):4553-8. PubMed ID: 23881924
[TBL] [Abstract][Full Text] [Related]
9. Pediatric-type diffuse low-grade glioma with
Kalelioglu T; Rama B; Cho BB; Lopes BM; Patel SH
Neuroradiol J; 2023 Apr; 36(2):232-235. PubMed ID: 36074655
[TBL] [Abstract][Full Text] [Related]
10. [Low grade glioma with MYBL1 alteration: Case report of an uncommon pediatric neoplasm].
Appay R; Tauziède-Espariat A; Silva K; Fritih R; Scavarda D; Delteil C; Varlet P; Figarella-Branger D
Ann Pathol; 2021 Feb; 41(1):129-133. PubMed ID: 32732147
[TBL] [Abstract][Full Text] [Related]
11. Brainstem angiocentric gliomas with MYB-QKI rearrangements.
D'Aronco L; Rouleau C; Gayden T; Crevier L; Décarie JC; Perreault S; Jabado N; Bandopadhayay P; Ligon KL; Ellezam B
Acta Neuropathol; 2017 Oct; 134(4):667-669. PubMed ID: 28803398
[No Abstract] [Full Text] [Related]
12. Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas.
Zhang J; Wu G; Miller CP; Tatevossian RG; Dalton JD; Tang B; Orisme W; Punchihewa C; Parker M; Qaddoumi I; Boop FA; Lu C; Kandoth C; Ding L; Lee R; Huether R; Chen X; Hedlund E; Nagahawatte P; Rusch M; Boggs K; Cheng J; Becksfort J; Ma J; Song G; Li Y; Wei L; Wang J; Shurtleff S; Easton J; Zhao D; Fulton RS; Fulton LL; Dooling DJ; Vadodaria B; Mulder HL; Tang C; Ochoa K; Mullighan CG; Gajjar A; Kriwacki R; Sheer D; Gilbertson RJ; Mardis ER; Wilson RK; Downing JR; Baker SJ; Ellison DW;
Nat Genet; 2013 Jun; 45(6):602-12. PubMed ID: 23583981
[TBL] [Abstract][Full Text] [Related]
13. Molecular genetics of ependymomas and pediatric diffuse gliomas: a short review.
Nobusawa S; Hirato J; Yokoo H
Brain Tumor Pathol; 2014 Oct; 31(4):229-33. PubMed ID: 25182241
[TBL] [Abstract][Full Text] [Related]
14. Recurrent Fusions in MYB and MYBL1 Define a Common, Transcription Factor-Driven Oncogenic Pathway in Salivary Gland Adenoid Cystic Carcinoma.
Brayer KJ; Frerich CA; Kang H; Ness SA
Cancer Discov; 2016 Feb; 6(2):176-87. PubMed ID: 26631070
[TBL] [Abstract][Full Text] [Related]
15. MYB, MYBL1, MYBL2 and NFIB gene alterations and MYC overexpression in salivary gland adenoid cystic carcinoma.
Fujii K; Murase T; Beppu S; Saida K; Takino H; Masaki A; Ijichi K; Kusafuka K; Iida Y; Onitsuka T; Yatabe Y; Hanai N; Hasegawa Y; Inagaki H
Histopathology; 2017 Nov; 71(5):823-834. PubMed ID: 28594149
[TBL] [Abstract][Full Text] [Related]
16. The conserved DNA binding domain mediates similar regulatory interactions for A-Myb, B-Myb, and c-Myb transcription factors.
Rushton JJ; Ness SA
Blood Cells Mol Dis; 2001; 27(2):459-63. PubMed ID: 11259168
[TBL] [Abstract][Full Text] [Related]
17. Angiocentric glioma with MYB-QKI fusion located in the brainstem, rather than cerebral cortex.
Chan E; Bollen AW; Sirohi D; Van Ziffle J; Grenert JP; Kline CN; Tihan T; Perry A; Gupta N; Solomon DA
Acta Neuropathol; 2017 Oct; 134(4):671-673. PubMed ID: 28776091
[No Abstract] [Full Text] [Related]
18. Distinct changes in gene expression induced by A-Myb, B-Myb and c-Myb proteins.
Rushton JJ; Davis LM; Lei W; Mo X; Leutz A; Ness SA
Oncogene; 2003 Jan; 22(2):308-13. PubMed ID: 12527900
[TBL] [Abstract][Full Text] [Related]
19. Small Subset of Adenoid Cystic Carcinoma of the Skin Is Associated With Alterations of the MYBL1 Gene Similar to Their Extracutaneous Counterparts.
Kyrpychova L; Vanecek T; Grossmann P; Martinek P; Steiner P; Hadravsky L; Belousova IE; Shelekhova KV; Svajdler M; Dubinsky P; Michal M; Kazakov DV
Am J Dermatopathol; 2018 Oct; 40(10):721-726. PubMed ID: 29570128
[TBL] [Abstract][Full Text] [Related]
20. Novel MYBL1 Gene Rearrangements with Recurrent MYBL1-NFIB Fusions in Salivary Adenoid Cystic Carcinomas Lacking t(6;9) Translocations.
Mitani Y; Liu B; Rao PH; Borra VJ; Zafereo M; Weber RS; Kies M; Lozano G; Futreal PA; Caulin C; El-Naggar AK
Clin Cancer Res; 2016 Feb; 22(3):725-33. PubMed ID: 26631609
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
